Canada markets closed

Obalon Therapeutics, Inc. (OBLN)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
1.5600-0.1400 (-8.24%)
At close: 4:00PM EST
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2019-12-31
2018-12-31
2017-12-31
Total Revenue
2,286
3,281
9,101
9,914
Cost of Revenue
2,259
2,950
5,423
4,829
Gross Profit
27
331
3,678
5,085
Operating Expenses
Research Development
5,711
6,893
10,697
10,647
Selling General and Administrative
14,357
16,668
29,946
28,829
Total Operating Expenses
20,068
23,561
40,643
39,476
Operating Income or Loss
-20,041
-23,230
-36,965
-34,391
Total Other Income/Expenses Net
-1,722
-61
-189
-239
Income Before Tax
-20,647
-23,676
-37,380
-34,765
Income from Continuing Operations
-20,647
-23,676
-37,380
-34,765
Net Income
-20,647
-23,676
-37,380
-34,765
Net Income available to common shareholders
-20,647
-23,676
-37,380
-34,765
Basic EPS
-
-5.03
-19.60
-20.80
Diluted EPS
-
-5.03
-19.60
-20.80
Basic Average Shares
-
4,707
1,904
1,672
Diluted Average Shares
-
4,707
1,904
1,672
EBITDA
-
-22,336
-36,384
-34,061